Oncology
Alpha-Fetoprotein (AFP)
Carcinoembryonic Antigen (CEA)
FOB & TF combo
Nuclear Matrix Protein 22 (NMP22)
Prostate Specific Antigen (PSA)
Nuclear Matrix Protein 22 (NMP22)
The Nuclear Matrix Protein 22 Test (NMP22) is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NUMA), which is an abundant component of the nuclear matrix proteins, in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer. This assay provides only a preliminary result. Clinical expertise and professional judgment should be sought to further evaluate the result of the test.
Some of the SKUs are available for sale exclusively outside the US. Please contact us for more information.
Ordering Information
PRODUCT DESCRIPTION
SPECIMEN
CATALOG NO.
FORMAT
CUT-OFF VALUE
KIT SIZE
QUALIFICATION
Nuclear Matrix Protein 22 Test
Urine
GENMP22-102a
Cassette
10 U/mL
25 Tests/Kit
/
The Genesis of Better Health
Copyright © Healgen SiteMap Privacy Policy Terms and Conditions Terms of Use